Video

Managing Small Renal Masses in Renal Cell Carcinoma VL

Search

Advancing Imaging Techniques for Small Renal Mass Diagnosis and Clinical Decision-Making - Sam Chang Details Zach Klaassen and Sam Chang discuss the ZIRCON trial, which highlights a novel PET-CT imaging modality targeting carbonic anhydrase IX (CAIX) for diagnosing small renal masses, particularly clear cell renal cell carcinoma (ccRCC). They emphasize its high sensitivity and specificity, non-invasive nature, and potential to reduce unnecessary biopsies and surgeries. The imaging tool aids in shared dec...
Functional Renal Imaging and Advances in Kidney Cancer Detection - Shankar Siva Details Phillip Koo interviews Shankar Siva about advancements in functional renal imaging. Dr. Siva discusses the current standard imaging for localized kidney cancer, which includes triple-phase CT or MRI with IV contrast, and the limitations of bone scans for detecting metastases. He highlights the potential of sestamibi scanning for identifying benign kidney conditions and the promising results from t...
Results from the Phase 3 Study of 89Zr-DFO-Girentuximab for PET/CT Imaging of Clear Cell Renal Cell Carcinoma (ZIRCON) - Brian Shuch Details Brian Shuch joins Pedro Barata to discuss the recent results from ZIRCON, a phase 3 study of 89 Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ccRCC). There is an unmet need for an accurate noninvasive method for pre-treatment risk stratification in detecting renal masses. The trial evaluated the efficacy of the imaging agent desferrioxamine-zirconium-girentuximab (Teli...